GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Compound S-D1 [WO2021155225A1] | FHD609
Compound class:
Synthetic organic
Comment: FHD-609 is a PROTAC degrader of bromodomain-containing protein 9 (BRD9), that was designed as a treatment for synovial sarcoma and SMARCB1-loss tumours. It is one of the compounds claimed in Foghorn Therapeutics' patent WO2021155225A1 [1]. FHD-609 is suitable for intravenous delivery.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
Synonyms ![]() |
| Compound S-D1 [WO2021155225A1] | FHD609 |
Database Links ![]() |
|
| GtoPdb PubChem SID | 483123307 |
| PubChem CID | 156817975 |
| Search Google for chemical match using the InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
| Search Google for chemicals with the same backbone | OBNRBCUHEAAFPS |
| UniChem Compound Search for chemical match using the InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
FHD-609 (links to external site)
Cat. No. HY-153367 |